Sherry M Wren

Title: Sherry M Wren: Innovator in Hematopoietic Research

Introduction

Sherry M Wren is an accomplished inventor based in Pittsburgh, PA, whose groundbreaking work has advanced the field of hematopoietic research. With a focus on the isolation and application of hematopoietic facilitatory cells, her contributions hold significant potential for medical treatments.

Latest Patents

Sherry M Wren has been granted a patent for her innovative work titled "Hematopoietic facilitatory cells and their uses." This patent relates to the unique properties of mammalian hematopoietic facilitatory cells (FC), which can be distinguished from other known bone marrow cells by their morphology, cell surface phenotype, and in vivo function. The invention highlights the importance of FC in enhancing the engraftment of hematopoietic stem cells and bone marrow cells in various therapeutic contexts.

Career Highlights

Wren's career is marked by her role at the University of Pittsburgh, where she has made significant strides in hematopoietic cell research. Her pioneering work suggests that by co-administering FC with other bone marrow cells, there is an enhancement of engraftment without adverse biological activities, paving the way for more effective treatments for cancers, immunodeficiencies, and other serious conditions.

Collaborations

Throughout her career, Wren has collaborated with esteemed colleagues, including Suzanne T Ildstad and Richard L Simmons. These partnerships have enriched her research and expanded the implications of her findings within the scientific community.

Conclusion

Sherry M Wren’s innovative contributions to hematopoietic research, particularly through her patent on hematopoietic facilitatory cells, demonstrate her commitment to advancing medical science. Her work not only enhances our understanding of cell transplantation but also holds promise for improving patient outcomes in various diseases.